Gritstone Oncology Taps Pfizer Veteran Karin Jooss As Its First CSO

Xconomy San Francisco — 

Emeryville, CA-based Gritstone Oncology named Karin Jooss as its chief scientific officer. Jooss was previously Pfizer’s head of cancer immunotherapeutics and immunopharmacology. She joins Gritstone six months after the company launched with a $102 million commitment from Versant Ventures, the Column Group, and several other investors.